1. Zeng, Wenfeng, Xiong, Lixiong, Wu, Wei, Chen, Jianing, Huang, Di. 2022. CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype. In Oncogene, 42, 224-237. doi:10.1038/s41388-022-02540-2. https://pubmed.ncbi.nlm.nih.gov/36418470/
2. Lin, Zeyu, Li, Wenbin, Zhang, Heyun, Wang, Jie, Ouyang, Nengtai. 2015. CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 3461-8. doi:10.1007/s13277-015-4172-x. https://pubmed.ncbi.nlm.nih.gov/26449829/
3. Korbecki, Jan, Olbromski, Mateusz, Dzięgiel, Piotr. 2020. CCL18 in the Progression of Cancer. In International journal of molecular sciences, 21, . doi:10.3390/ijms21217955. https://pubmed.ncbi.nlm.nih.gov/33114763/
4. Köhn, Linda, Kohl, Susanne, Bowne, Sara J, Sandgren, Ola, Golovleva, Irina. . PITPNM3 is an uncommon cause of cone and cone-rod dystrophies. In Ophthalmic genetics, 31, 139-40. doi:10.3109/13816810.2010.486776. https://pubmed.ncbi.nlm.nih.gov/20590364/
5. Reinis, Ainars, Golovleva, Irina, Köhn, Linda, Sandgren, Ola. 2012. Ocular phenotype of CORD5, an autosomal dominant retinal dystrophy associated with PITPNM3 p.Q626H mutation. In Acta ophthalmologica, 91, 259-66. doi:10.1111/j.1755-3768.2011.02381.x. https://pubmed.ncbi.nlm.nih.gov/22405330/
智鼠故事 
